Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSCT Engraftment”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT02099266
What this trial is testing

Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome (MDS)+2 more
University of Kansas Medical Center 15
Testing effectiveness (Phase 2)Ended earlyNCT02963064
What this trial is testing

JSP191 Antibody Targeting Conditioning in SCID Patients

Who this might be right for
SCID
Jasper Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00636909
What this trial is testing

Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more
Beth Israel Deaconess Medical Center 25
Testing effectiveness (Phase 2)Ended earlyNCT06102213
What this trial is testing

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematologic Malignancy
Prolacta Bioscience 46
Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Testing effectiveness (Phase 2)Study completedNCT00119340
What this trial is testing

Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 75
Large-scale testing (Phase 3)UnknownNCT02240992
What this trial is testing

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionDelayed Platelet Engraftment+1 more
Nanfang Hospital, Southern Medical University 120
Early research (Phase 1)UnknownNCT04709458
What this trial is testing

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Who this might be right for
MyelofibrosisAcute Myelogenous Leukemia
Taiga Biotechnologies, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT00526734
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Erasme University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT03214354
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Who this might be right for
Sickle Cell DiseaseStem Cell Transplant ComplicationsRed Blood Cell Disorder+1 more
University of Calgary 12
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Not applicableStudy completedNCT01468935
What this trial is testing

Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning

Who this might be right for
EndometriosisStem Cell TransplantHealthy Volunteers
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 79
Not applicableStudy completedNCT01622582
What this trial is testing

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 796
Not applicableStudy completedNCT07747246
What this trial is testing

Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCT

Who this might be right for
Thrombocytopenia
Tongji Hospital 103
Large-scale testing (Phase 3)Study completedNCT01471444
What this trial is testing

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Disorder Related to Bone Marrow TransplantationLeukemiaTransplantation Infection
M.D. Anderson Cancer Center 256
Testing effectiveness (Phase 2)WithdrawnNCT01882387
What this trial is testing

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Early research (Phase 1)Study completedNCT00092937
What this trial is testing

Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

Who this might be right for
Granulomatous DiseaseChronic
National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)Study completedNCT00006413
What this trial is testing

Stem Cell Transplantation to Treat Systemic Mastocytosis

Who this might be right for
Mastocytosis
National Heart, Lung, and Blood Institute (NHLBI) 25
Next Page